about
Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherenceAccumulation of cardiovascular and diabetes medication among apparently healthy statin initiatorsFunctional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: the Kuopio ischaemic heart disease risk factor study.Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in FinlandLifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities.Coexisting social conditions and health problems among clients seeking treatment for illicit drug use in Finland: the HUUTI study.Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events.Childhood adversity as a predictor of non-adherence to statin therapy in adulthoodInfluence of Retirement on Adherence to Statins in the Insurance Medicine All-Sweden Total Population Data Base.Statins and hip fracture prevention--a population based cohort study in womenNatural history of bleeding and characteristics of early bleeders among warfarin initiators - a cohort study in Finland.Influence of retirement on nonadherence to medication for hypertension and diabetes.Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis.Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.Prevalence of concomitant use of alcohol and sedative-hypnotic drugs in middle and older aged persons: a systematic review.Co-Prescribing of Potentially Interacting Drugs during Warfarin Therapy - A Population-Based Register Study.Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?Somatic symptoms of anxiety and nonadherence to statin therapy.Changes in alcohol consumption and drinking patterns during 11 years of follow-up among ageing men: the FinDrink study.Antidepressant use and work-related injuries.Potential contribution of lifestyle and socioeconomic factors to healthy user bias in antihypertensives and lipid-lowering drugs.Epidermal cell culture model with tight stratum corneum as a tool for dermal gene delivery studies.Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.Cardiovascular risk profile and use of statins at the age of 70 years: a comparison of two Finnish birth cohorts born 20 years apart.Adherence to statin therapy and the incidence of ischemic stroke in patients with diabetes.Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence--estimates from the Finnish prescription register.Sociodemographic characteristics and drug abuse patterns of treatment-seeking illicit drug abusers in Finland, 1997-2008: the Huuti study.Non-pharmacological treatment of hypertension in primary health care: a 2-year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland.Impact of restricted reimbursement on the use of statins in Finland: a register-based study.Odor annoyance near waste treatment centers: a population-based study in Finland.Suboptimal use of statins at treatment initiation.Mortality among clients seeking treatment for buprenorphine abuse in Finland.The effect of intensified diet counseling on the diet of hypertensive subjects in primary health care: a 2-year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland.Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland.Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland.Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study.Serum homocysteine, folate and risk of stroke: Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study.Risk drinking behavior among psychotropic drug users in an aging Finnish population: the FinDrink study.Statin use among older Finns stratified according to cardiovascular risk.Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists.
P50
Q24658518-592FA9A0-52EE-46F3-B673-371DCFA64EA9Q28543231-0BB27BEE-64AF-42C4-A820-625CE216DE33Q33271016-D691BD93-4A5C-4B49-85C9-F6FC65398426Q33795544-D4703A4B-42EA-4595-8F0F-24D2AFFA165DQ34115208-C4D456E1-7C20-4203-B7B6-A75593EA3ACAQ34687009-5D65182B-A713-48A6-ABD1-B9985943F9D6Q35116507-C9343A10-CBCE-40DF-B2B6-BDC8AEC802B8Q35642146-6C951CC2-954E-4F62-A3BD-B425C782067CQ35671834-6344244B-AE4F-429B-94F6-B1C83A88D8B4Q36353931-810C1138-68DC-43D7-9456-5599FAB2E4B4Q36575256-8ACBD518-3670-41B6-A8BF-CBDCB757F787Q37321302-069207B6-245B-415B-9F91-7B1865D2B799Q37547210-BDB71AD1-745A-447E-9ECF-8B71DDA5D9D8Q37570327-7C68BF2C-8E09-458C-94ED-5408373FCDA6Q38077740-620C6BF2-66FF-40E6-9699-F98D6E3FCC6CQ38417110-1A81624F-4103-414A-9DB4-6D35FB4A5AF5Q39274468-B6632FD7-40E0-4B23-AC6B-9EB4ACFDBEBDQ39834328-CB794325-B7DA-4BB1-8F59-DAC9EF1D7CC2Q39967367-555B8BA8-7284-4F41-A283-79CCF1D60576Q40068322-41999044-ADFE-471C-8FC9-650A57112587Q40100271-33EC69EE-B89C-4282-B733-55F5D79B1286Q40349784-15941F4C-997B-40E4-9640-92A3E358ADFCQ40497619-56596D3C-12D4-4732-9A7C-D2D41BD72AD3Q40978830-D794BFAC-0197-4992-90C5-AB30ED03E930Q41034501-7653D06E-3251-4399-B16C-D9FA5CE82EDFQ41532022-D614D1F3-B491-4858-8494-9756D479296BQ42282441-03FA530C-A86E-4E70-BFC6-3E5EF3942802Q42690242-6856BE5C-3209-4745-8235-189B862469AAQ42938860-B638FDF0-6ABD-468E-A206-4CEE2950C923Q43316990-E54FB81D-0CFD-47DA-B912-C568B769BA66Q43484888-F96548FE-7962-4FB8-BF01-B7F6A89D222DQ43583622-0AE6ED60-38C9-4E77-9410-DD7B5B53D26EQ44243206-D348ACAC-CF59-4FB3-9474-E38FDECD8679Q44871003-B3717BF3-B9E7-4F5A-9183-8622D030E160Q45147993-DF02D7FF-B851-4E66-A9C9-5C77706C4498Q45269281-E5AC80F7-9ECE-4AD2-B16E-F3AC4966E889Q46634103-1F06D6CE-DD1B-4E5D-829E-875238CEB08AQ46654298-EAB997DB-9627-4474-8963-25734799450EQ46888848-6D93AA3B-1120-4B0F-86B7-D3937EE9451FQ47157796-196A3ACB-6EC0-4E2A-AADE-5BA95D9746B4
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maarit Korhonen
@ast
Maarit Korhonen
@en
Maarit Korhonen
@es
Maarit Korhonen
@nl
Maarit Korhonen
@sl
type
label
Maarit Korhonen
@ast
Maarit Korhonen
@en
Maarit Korhonen
@es
Maarit Korhonen
@nl
Maarit Korhonen
@sl
prefLabel
Maarit Korhonen
@ast
Maarit Korhonen
@en
Maarit Korhonen
@es
Maarit Korhonen
@nl
Maarit Korhonen
@sl
P108
P106
P1153
7005876696
P21
P31
P496
0000-0002-2953-4757